Molecular Biology of the Cell Call for Nominations: MBC Editor-in-Chief

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E03-06-0403 on October 17, 2003

Vol. 14, Issue 12, 5060-5068, December 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-06-0403v1
14/12/5060    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, B.
Right arrow Articles by de Lange, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, B.
Right arrow Articles by de Lange, T.

Rap1 Affects the Length and Heterogeneity of Human Telomeres

Bibo Li, and Titia de Lange *

The Rockefeller University, New York, New York 10021

Submitted June 16, 2003; Revised August 7, 2003; Accepted August 8, 2003
Monitoring Editor: Joseph Gall

Telomere length is controlled in part by cis-acting negative regulators that limit telomere extension by telomerase. In budding yeast, the major telomere length regulator scRap1 binds to telomeric DNA and acts to inhibit telomere elongation in cis. Because the human Rap1 ortholog hRap1 does not bind to telomeric DNA directly but is recruited to telomeres by TRF2, we examined its role in telomere length control. The data are consistent with hRap1 being a negative regulator of telomere length, indicating functional conservation. Deletion mapping confirmed that hRap1 is tethered to telomeres through interaction of its C terminus with TRF2. The telomere length phenotypes of hRap1 deletion mutants implicated both the BRCT and Myb domain as protein interaction domains involved in telomere length regulation. By contrast, scRap1 binds to telomeres with its Myb domains and uses its C terminus to recruit the telomere length regulators Rif1 and Rif2. Together, our data show that although the role of Rap1 at telomeres has been largely conserved, the domains of Rap1 have undergone extensive functional changes during eukaryotic evolution. Surprisingly, hRap1 alleles lacking the BRCT domain diminished the heterogeneity of human telomeres, indicating that hRap1 also plays a role in the regulation of telomere length distribution.


* Corresponding author. E-mail address: delange{at}mail.rockefeller.edu.




This article has been cited by other articles:


Home page
Genes Dev.Home page
M. P. Longhese
DNA damage response at functional and dysfunctional telomeres
Genes & Dev., January 15, 2008; 22(2): 125 - 140.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Lin, J. Gu, C. Lu, M. R. Spitz, and X. Wu
Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Clin. Cancer Res., October 1, 2006; 12(19): 5720 - 5725.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Churikov, C. Wei, and C. M. Price
Vertebrate POT1 Restricts G-Overhang Length and Prevents Activation of a Telomeric DNA Damage Checkpoint but Is Dispensable for Overhang Protection.
Mol. Cell. Biol., September 1, 2006; 26(18): 6971 - 6982.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Goldkorn and E. H. Blackburn
Assembly of Mutant-Template Telomerase RNA into Catalytically Active Telomerase Ribonucleoprotein That Can Act on Telomeres Is Required for Apoptosis and Cell Cycle Arrest in Human Cancer Cells
Cancer Res., June 1, 2006; 66(11): 5763 - 5771.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D.-H. Zhang, B. Zhou, Y. Huang, L.-X. Xu, and J.-Q. Zhou
The human Pif1 helicase, a potential Escherichia coli RecD homologue, inhibits telomerase activity
Nucleic Acids Res., March 6, 2006; 34(5): 1393 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
O. Dreesen, B. Li, and G. A. M. Cross
Telomere structure and shortening in telomerase-deficient Trypanosoma brucei
Nucleic Acids Res., August 9, 2005; 33(14): 4536 - 4543.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Xu and E. H. Blackburn
Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules
J. Cell Biol., December 6, 2004; 167(5): 819 - 830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. N. Karamysheva, Y. V. Surovtseva, L. Vespa, E. V. Shakirov, and D. E. Shippen
A C-terminal Myb Extension Domain Defines a Novel Family of Double-strand Telomeric DNA-binding Proteins in Arabidopsis
J. Biol. Chem., November 12, 2004; 279(46): 47799 - 47807.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
F. d'Adda di Fagagna, S.-H. Teo, and S. P. Jackson
Functional links between telomeres and proteins of the DNA-damage response
Genes & Dev., August 1, 2004; 18(15): 1781 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. O'Connor, A. Safari, D. Liu, J. Qin, and Z. Songyang
The Human Rap1 Protein Complex and Modulation of Telomere Length
J. Biol. Chem., July 2, 2004; 279(27): 28585 - 28591.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Blasco
Telomere epigenetics: a higher-order control of telomere length in mammalian cells
Carcinogenesis, July 1, 2004; 25(7): 1083 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Erdmann, Y. Liu, and L. Harrington
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice
PNAS, April 20, 2004; 101(16): 6080 - 6085.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2003 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.